Ackermann, Ronald T.

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine

Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management

Cited by 703

Translating the Diabetes Prevention Program into the Community

Ackermann, R. T., Finch, E. A., Brizendine, E., Zhou, H., & Marrero, D. G. (2008) · American Journal of Preventive Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Education

Cited by 622

The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up

Aroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism

Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 467

Garlic Shows Promise for Improving Some Cardiovascular Risk Factors

Ackermann, R. T., Mulrow, C. D., Ramirez, G., Gardner, C. D., Morbidoni, L., & Lawrence, V. A. (2001) · Archives of Internal Medicine

Garlic and Onion StudiesLipoproteins and Cardiovascular Health

Cited by 295

Adapting the Diabetes Prevention Program Lifestyle Intervention for Delivery in the Community

Ackermann, R. T., & Marrero, D. G. (2007) · The Diabetes Educator

Diabetes Management and EducationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 220

Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 128

Identifying Adults at High Risk for Diabetes and Cardiovascular Disease Using Hemoglobin A1c

Ackermann, R. T., Cheng, Y. J., Williamson, D. F., & Gregg, E. W. (2011) · American Journal of Preventive Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 111

Understanding the Gap Between Good Processes of Diabetes Care and Poor Intermediate Outcomes: Translating Research Into Action for Diabetes (TRIAD)

Selby, J. V., Swain, B. E., Gerzoff, R. B., Karter, A. J., Waitzfelder, B. E., Brown, A. F., Ackermann, R. T., Duru, O. K., Ferrara, A., Herman, W., et al. (2007) · Medical Care

Diabetes Management and EducationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 73

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

A Theoretically Grounded Systematic Review of Material Incentives for Weight Loss: Implications for Interventions

Burns, R. J., Donovan, A. S., Ackermann, R. T., Finch, E. A., Rothman, A. J., & Jeffery, R. W. (2012) · Annals of Behavioral Medicine

Behavioral Health and InterventionsObesity, Physical Activity, Diet

Cited by 67

Evidence and challenges for translation and population impact of the Diabetes Prevention Program.

Ackermann, R. T., & O’Brien, M. J. (2020) · Current Diabetes Reports

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Education

Cited by 62

Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study

Ackermann, R. T., Finch, E. A., Caffrey, H. M., Lipscomb, E. R., Hays, L. M., & Saha, C. (2011) · Chronic Illness

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Education

Cited by 58

Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial

Knowler, W. C., Doherty, L., Edelstein, S. L., Bennett, P. H., Dabelea, D., Hoskin, M., Kahn, S. E., Kalyani, R. R., Kim, C., Pi-Sunyer, F. X., et al. (2025) · The Lancet Diabetes & Endocrinology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 39

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Effect on Health Care Expenditures During Nationwide Implementation of the Diabetes Prevention Program as a Health Insurance Benefit

Ackermann, R. T., Kang, R., Cooper, A. J., Liss, D. T., Holmes, A. M., Moran, M., & Saha, C. (2019) · Diabetes Care

Diabetes Management and EducationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 22

Costs for commercially insured adults prescribed second-line diabetes medications

Liss, D. T., Kang, R. H., Lancki, N., O'Brien, M. J., Wallia, A., Cooper, A. J., Harris, S. A., Parker, E. D., & Ackermann, R. T. (2021) · The American Journal of Managed Care

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 5